Vimarsana
Biggest News Aggregation in the World

Page 40 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

ICON to Partner With US Govt Agency to Test COVID Vaccine Candidates - Vimarsana News

ICON to Partner With US Govt Agency to Test COVID Vaccine Candidates

Contract research firm ICON said on Wednesday it is partnering with the US government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.

To Resect or Not to Resect in Stage III NSCLC - Vimarsana News

To Resect or Not to Resect in Stage III NSCLC

When is stage III NSCLC resectable? Experts attempted to reach a consensus on when to perform surgery.

ADCs Show Early Promise in NSCLC - Vimarsana News

ADCs Show Early Promise in NSCLC

Antibody-drug conjugates link a tumor-targeted antibody to a cytotoxic drug through a chemical linker and hold the promise of high potency.

Parity for OCT, IVUS in Intravascular Imaging-Guided PCI - Vimarsana News

Parity for OCT, IVUS in Intravascular Imaging-Guided PCI

The two types of imaging catheter, as guides for coronary stent targeting and deployment, led to similar clinical outcomes in the OCTIVUS trial. A meta-analysis backed it up.

Company Submits Supplemental NDA for Topical AD Treatment - Vimarsana News

Company Submits Supplemental NDA for Topical AD Treatment

Submission is based on positive results from two phase 3, vehicle-controlled trials in patients ages 6 and older with mild to moderate AD.